Significance of metabolomic disorders in infertility and miscarriage in patients with endometriosis
- Authors: Ermolova N.V.1, Levkovich M.A.1, Petrov Y.A.1, Avrutskaya V.V.1, Krukier I.I.1, Savchenko A.V.1
-
Affiliations:
- Rostov State Medical University
- Issue: Vol 71, No 4 (2022)
- Pages: 21-31
- Section: Original Research
- URL: https://journals.rcsi.science/jowd/article/view/106001
- DOI: https://doi.org/10.17816/JOWD106001
- ID: 106001
Cite item
Abstract
BACKGROUND: Despite numerous studies, the causal relationships of endometriosis, associated infertility and miscarriage have not yet been clarified.
AIM: This article discusses the significance of insulin-like growth factor 1, matrix metalloproteinase 9 and activin A levels in the blood serum and peritoneal fluid of patients of reproductive age with endometriosis in the clinical aspects of infertility and miscarriage and as per stages of the disease.
MATERIALS AND METHODS: The overall group consisted of patients with endometriosis (group I: stages I–II, n = 25; group II: stages III–IV, n = 38). The control group comprised patients without the disease (group III: n = 25). The stage of endometriosis was classified during laparoscopy in accordance with revised American Society for Reproductive Medicine classification (1996).
RESULTS: In endometriosis, primary infertility predominated (up to 40.8% of cases), while secondary infertility occured in 21.2% of cases. Primary infertility accounted for 68.0% of cases in stages I–II versus 39.5% of cases in stages III–IV. Secondary infertility accounted for 28.0% versus 23.0% of cases, respectively. In minimal stages of the disease, non-developing pregnancies (12.0%) and spontaneous miscarriages (4.0%) occurred in 16.0% of cases. In severe stages, these nosologies occurred in an equal percentage of cases (5.2%).
The group of patients with endometriosis showed multidirectional changes in activin A levels in the blood serum and peritoneal fluid, a decrease in matrix metalloproteinase 9 level by 27% in the peritoneal fluid and an increase in insulin-like growth factor 1 level by 36% in the blood serum. In minimal stages of endometriosis, the tendencies of changes in the parameters remained intact as compared to the overall group, the correspondence of matrix metalloproteinase 9 levels to the control values in the blood serum and peritoneal fluid being noteworthy. Stages III–IV of the disease implied more significant changes as compared to the control or the overall group of patients. We found a decrease in insulin-like growth factor 1 level by 56% in the peritoneal fluid, a decrease in activin A level by 19% in the blood serum with an increase in the parameter by 27% in the peritoneal fluid, and a decrease in matrix metalloproteinase 9 level by 4% in the peritoneal fluid.
CONCLUSIONS: Modifications of the studied compounds activin A, MPP-9 and IPFR-1 are associated with infertility and miscarriage in patients with endometriosis.
Full Text
##article.viewOnOriginalSite##About the authors
Natalya V. Ermolova
Rostov State Medical University
Author for correspondence.
Email: rniiap.ermolova@gmail.com
SPIN-code: 1130-1167
MD, Dr. Sci. (Med.), Assistant Professor
Russian Federation, Rostov-on-DonMarina A. Levkovich
Rostov State Medical University
Email: xlma@mail.ru
SPIN-code: 2964-0480
MD, Dr. Sci. (Med.), Assistant Professor
Russian Federation, Rostov-on-DonYury A. Petrov
Rostov State Medical University
Email: mr.doctorpetrov@mail.ru
SPIN-code: 1582-0468
MD, Dr. Sci. (Med.), Professor
Russian Federation, Rostov-on-DonValeria V. Avrutskaya
Rostov State Medical University
Email: v.avrutskaya@rniiap.ru
SPIN-code: 9495-9702
MD, Dr. Sci. (Med.), Assistant Professor
Russian Federation, Rostov-on-DonIrina I. Krukier
Rostov State Medical University
Email: biochem@rniiap.ru
SPIN-code: 4975-1350
Dr. Sci. (Biol.)
Russian Federation, Rostov-on-DonAnastasia V. Savchenko
Rostov State Medical University
Email: savnas2014@yandex.ru
ординатор кафедры акушерства и гинекологии №1
Russian Federation, Rostov-on-DonReferences
- Adamyan LV, Farkhat KN, Makiyan ZN, Savilova AM. The external genital endometriosis: theories and molecular investigation (a review). Problemy reproduktsii. 2015;21(5):8−16. (In Russ.)
- Giudice LC, Kao LC. Endometriosis. Lancet. 2004;364(9447):1789−1799. doi: 10.1016/S0140-6736(04)17403-5
- Working group of ESGE, ESHRE, and WES; Saridogan E, Becker CM, et al. Recommendations for the surgical treatment of endometriosis-part 1: ovarian endometrioma. Gynecol Surg. 2017;14(1):27. doi: 10.1186/s10397-017-1029-x
- Dunselman GA, Vermeulen N, Becker C, et al. ESHRE guideline: management of women with endometriosis. Hum Reprod. 2014;29(3):400−412. doi: 10.1093/humrep/det457
- Besplodiye i endometrioz. Versii i kontraversii. Ed. by V.E. Radzinskii, M.R. Orazov. Moscow: Status Praesens; 2019. (In Russ.)
- Kohl Schwartz AS, Wölfler MM, Mitter V, et al. Endometriosis, especially mild disease: a risk factor for miscarriages. Fertil Steril. 2017;108(5):806−814.e2. doi: 10.1016/j.fertnstert.2017.08.025
- Macer ML, Taylor HS. Endometriosis and infertility: a review of the pathogenesis and treatment of endometriosis-associated infertility. Obstet Gynecol Clin North Am. 2012;39(4):535−549. doi: 10.1016/j.ogc.2012.10.002
- Yarmolinskaya MI, Sel’kov SA. Peculiarities of pregnancy planning and management of pregnancy in women with pelvic endometrios. Journal of Obstetrics and Women’s Diseases. 2011;(3):176−185. (In Russ.)
- Leonardi M, Papaleo E, Reschini M, et al. Risk of miscarriage in women with endometriosis: insights from in vitro fertilization cycles. Fertil Steril. 2016;106(2):386−392.e3. doi: 10.1016/j.fertnstert.2016.03.047
- Sourial S, Tempest N, Hapangama DK. Theories on the pathogenesis of endometriosis. Int J Reprod Med. 2014;2014:179515. doi: 10.1155/2014/179515
- Lessey BA, Young SL. Homeostasis imbalance in the endometrium of women with implantation defects: the role of estrogen and progesterone. Semin Reprod Med. 2014;32(5):365−375. doi: 10.1055/s-0034-1376355
- Roy RN, Cecutti A, Gerulath AH, et al. Endometrial transcripts of human insulin-like growth factors arise by differential promoter usage. Mol Cell Endocrinol. 1997;135(1):11−19. doi: 10.1016/s0303-7207(97)00181-0
- Zachow RJ, Magoffin DA. Direct intraovarian effects of leptin: impairment of the synergistic action of insulin-like growth factor-I on follicle-stimulating hormone-dependent estradiol-17 beta production by rat ovarian granulosa cells. Endocrinology. 1997;138(2):847−850. doi: 10.1210/endo.138.2.5035
- Ermolova NV. Patogeneticheskiye mekhanizmy formirovaniya naruzhnogo genital’nogo endometrioza i yego stadiy u patsiyentok reproduktivnogo vozrasta. [dissertation abstract]. Rostov-na-Donu; 2009. [cited 2022 Jan 14]. Available from: https://www.dissercat.com/content/patogeneticheskie-mekhanizmy-formirovaniya-naruzhnogo-genitalnogo-endometrioza-i-ego-stadii- (In Russ.)
- Saprunova VB, Kazimirchuk SA, Tonshin AA, et al. Induction of apoptosis in rat myocardium under anoxic conditions. Biochemistry. 2002;67(2):293−302. (In Russ.)
- Seli E, Berkkanoglu M, Arici A. Pathogenesis of endometriosis. Obstet Gynecol Clin North Am. 2003;30(1):41−61. doi: 10.1016/s0889-8545(02)00052-9
- Osteen KL, Bruner-Tran KL. Matrix metalloproteinases and endometriosis. In: Endometriosis in clinical practice. Ed. by O. Olive. Oxford; 2005:147−158.
- Karas R, Clarkson TB. Cardiovascular effects of hormone replacement therapy observed in the WHI: timing is everything. Menopausal Medicine. 2003;10(4):8−12.
- Sonova MM, Osipova AA. Rol’ makrofagov peritoneal’noy zhidkosti pri naruzhnom genital’nom endometrioze. In: Materialy IX Vserossiyskogo nauchnogo foruma “Mat’ i ditya”. Moscow; 2007:522−523. (In Russ.)
- Stilley JA, Sharpe-Timms KL. TIMP1 contributes to ovarian anomalies in both an MMP-dependent and -independent manner in a rat model. Biol Reprod. 2012;86(2):47. doi: 10.1095/biolreprod.111.094680
- Muttukrishna S, Jauniaux E, Greenwold N, et al. Circulating levels of inhibin A, activin A and follistatin in missed and recurrent miscarriages. Hum Reprod. 2002;17(12):3072−3078. doi: 10.1093/humrep/17.12.3072
- Tessier C, Prigent-Tessier A, Bao L, et al. Decidualactivin: its role in the apoptotic process and its regulation by prolactin. Biol Reprod. 2003;68(5):1687−1694. doi: 10.1095/biolreprod.102.011684
- Ogawa K, Funaba M, Chen Y, et al. Activin A functions as a Th2 cytokine in the promotion of the alternative activation of macrophages. J Immunol. 2006;177(10):6787−6794. doi: 10.4049/jimmunol.177.10.6787
- Kondrikov NI, Barinova IV. Patologiya matki. 2nd ed. Moscow: Prakticheskaya meditsina; 2019. (In Russ.)
- Avanesova TG, Levkovich MA, Ermolova NV, et al. The role of interleukin-8 (IL-8) and polymorphism of IL-8 gene in formation of external genital endometriosis in patients of reproductive age. Obstetrics and Gynecology. 2021;(3):124−129. (In Russ.). doi: 10.18565/aig.2021.3.124-129
- Practice Committee of the American Society for Reproductive Medicine. Endometriosis and infertility: a committee opinion. Fertil Steril. 2012;98(3):591−598. doi: 10.1016/j.fertnstert.2012.05.031
- Barbosa MA, Teixeira DM, Navarro PA, et al. Impact of endometriosis and its staging on assisted reproduction outcome: systematic review and meta-analysis. Ultrasound Obstet Gynecol. 2014;44(3):261−278. doi: 10.1002/uog.13366
- Forster R, Sarginson A, Velichkova A, et al. Macrophage-derived insulin-like growth factor-1 is a key neurotrophic and nerve-sensitizing factor in pain associated with endometriosis. FASEB J. 2019;33(10):11210−11222. doi: 10.1096/fj.201900797R
- Sbracia M, Zupi E, Alo P, et al. Differential expression of IGF-I and IGF-II in eutopic and ectopic endometria of women with endometriosis and in women without endometriosis. Am J ReprodImmunol. 1997;37(4):326−329. doi: 10.1111/j.1600-0897.1997.tb00238.x
- Reis FM, Petraglia F, Taylor RN. Endometriosis: hormone regulation and clinical consequences of chemotaxis and apoptosis. Hum Reprod Update. 2013;19(4):406−418. doi: 10.1093/humupd/dmt010
- Zheng J, Qu J, Lu P, et al. Activin a stimulates aromatase via the alk4-smad pathway in endometriosis. Biomed Res Int. 2016;2016:5791510. doi: 10.1155/2016/5791510
- Levkovich MA, Ermolova NV, Krukier II, et al. Indicators of activin A in patients with external genital endometriosis. Russian Journal of Allergy. 2019;16(2):93−95. (In Russ.). doi: 10.36691/RJA1203
- Luisi S, Pinzauti S, Regini C, et al. Serum markers for the noninvasive diagnosis of endometriosis. Womens Health. 2015;11(5):603−610. doi: 10.2217/whe.15.46
- Curry TE, Osteen KG. The matrix metalloproteinase system: changes, regulation, and impact throughout the ovarian and uterine reproductive cycle. Endocr Rev. 2003;24(4):428−465. doi: 10.1210/er.2002-0005
- Collette T, Bellehumeur C, Kats R, et al. Evidence for an increased release of proteolytic activity by the eutopic endometrial tissue in women with endometriosis and for involvement of matrix metalloproteinase-9. Hum Reprod. 2004;19(6):1257−1264. doi: 10.1093/humrep/deh290
- Szymanowski K, Niepsuj-Biniaś J, Dera-Szymanowska A, et al. An influence of immunomodulation on Th1 and Th2 immune response in endometriosis in an animal model. Biomed Res Int. 2013;2013:849492. doi: 10.1155/2013/849492
- Bostanci Durmus A, Dincer Cengiz S, Yılmaz H, et al. The levels of matrix metalloproteinase-9 and neutrophil gelatinase-associated lipocalin in different stages of endometriosis. J Obstet Gynaecol. 2019;39(7):991−995. doi: 10.1080/01443615.2019.1584889
- Nanda A, Thaganpandi K, Banerjee P, et al. Cytokines, angiogenesis, and extracellular matrix degradation are augmented by oxidative stress in endometriosis. Ann Lab Med. 2020;40(5):390−397. doi: 10.3343/alm.2020.40.5.390
- Yarmolinskaya MI, Molotkov AS, Denisova VM. The role of matrix metalloproteinases in pathogenesis of genital endometriosis. Journal of Obstetrics and Women’s Diseases. 2012;61(2):92−100.